Teva Pharmaceutical Industries Ltd
TEVA28.460USD
+0.040+0.14%
終値 12/05, 16:00（ET）15分遅れの株価
32.65B時価総額
45.86直近12ヶ月PER
詳細情報 Teva Pharmaceutical Industries Ltd 企業名
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltdの企業情報
企業コードTEVA
会社名Teva Pharmaceutical Industries Ltd
上場日Jan 01, 1951
最高経営責任者「CEO」Mr. Richard D. Francis
従業員数33892
証券種類Ordinary Share
決算期末Jan 01
本社所在地124 Dvora Hanevi'a St.
都市TEL AVIV-YAFO
証券取引所Tel Aviv Stock Exchange
国Israel
郵便番号6944020
電話番号97239148213
ウェブサイトhttps://www.tevapharm.com/
企業コードTEVA
上場日Jan 01, 1951
最高経営責任者「CEO」Mr. Richard D. Francis
Teva Pharmaceutical Industries Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
13.03K
+9.34%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Eliyahu Sharon (Eli) Kalif
Mr. Eliyahu Sharon (Eli) Kalif
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Matthew Shields
Mr. Matthew Shields
Executive Vice President - Teva Global Operations
Executive Vice President - Teva Global Operations
--
--
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
13.03K
+9.34%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
収益内訳
通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Generic products
2.41B
57.73%
AUSTEDO
498.00M
11.93%
Anda
365.00M
8.74%
Other
247.00M
5.91%
AJOVY
154.00M
3.69%
他の
501.00M
12.00%
地域別USD
会社名
収益
比率
United States
2.15B
51.51%
Europe
1.30B
31.06%
International Markets
495.00M
11.85%
Other
232.00M
5.56%
事業別
地域別
事業別USD
会社名
収益
比率
Generic products
2.41B
57.73%
AUSTEDO
498.00M
11.93%
Anda
365.00M
8.74%
Other
247.00M
5.91%
AJOVY
154.00M
3.69%
他の
501.00M
12.00%
株主
更新時刻: Sun, Nov 16
更新時刻: Sun, Nov 16
株主統計
種類
株主統計
株主統計
比率
Phoenix Investment and Finances Ltd
3.60%
Menora Mivtachim Insurance Ltd.
3.39%
Harel Insurance Investments and Financial Services Ltd
3.29%
BlackRock Institutional Trust Company, N.A.
3.04%
Migdal Insurance and Financial Holdings Ltd
2.84%
他の
83.84%
株主統計
株主統計
比率
Phoenix Investment and Finances Ltd
3.60%
Menora Mivtachim Insurance Ltd.
3.39%
Harel Insurance Investments and Financial Services Ltd
3.29%
BlackRock Institutional Trust Company, N.A.
3.04%
Migdal Insurance and Financial Holdings Ltd
2.84%
他の
83.84%
種類
株主統計
比率
Investment Advisor
22.92%
Investment Advisor/Hedge Fund
12.47%
Hedge Fund
10.45%
Insurance Company
6.24%
Research Firm
2.35%
Pension Fund
1.69%
Family Office
1.47%
Bank and Trust
0.90%
Sovereign Wealth Fund
0.24%
他の
41.26%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
1124
742.23M
64.70%
-84.92M
2025Q2
1100
749.18M
65.31%
-13.97M
2025Q1
1130
727.69M
63.46%
-282.41K
2024Q4
1087
683.52M
59.66%
-22.86M
2024Q3
1029
663.95M
58.60%
-6.13M
2024Q2
1002
631.05M
55.72%
-26.20M
2024Q1
950
595.83M
53.15%
-34.73M
2023Q4
932
601.27M
53.63%
+7.51M
2023Q3
929
573.53M
51.16%
-84.22M
2023Q2
921
512.98M
45.79%
-122.32M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Phoenix Investment and Finances Ltd
37.76M
3.29%
+10.30M
+37.49%
Jun 30, 2025
Menora Mivtachim Insurance Ltd.
57.40M
5%
+18.90M
+49.10%
Jul 16, 2025
Harel Insurance Investments and Financial Services Ltd
33.39M
2.91%
+11.33M
+51.39%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
33.89M
2.95%
+833.03K
+2.52%
Jun 30, 2025
Migdal Insurance and Financial Holdings Ltd
28.69M
2.5%
+2.35M
+8.92%
Jun 30, 2025
Clal Insurance Enterprises Holdings Ltd.
32.36M
2.82%
-5.43M
-14.37%
Jun 30, 2025
Lingotto Investment Management LLP
28.16M
2.45%
+302.98K
+1.09%
Jun 30, 2025
Rubric Capital Management LP
26.00M
2.27%
+450.00K
+1.76%
Jun 30, 2025
PointState Capital LP
20.71M
1.81%
+5.58M
+36.88%
Jun 30, 2025
Fidelity Management & Research Company LLC
50.63M
4.41%
-24.67M
-32.76%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares MSCI Israel ETF
7.76%
VanEck Israel ETF
7.5%
VanEck Pharmaceutical ETF
3.79%
First Trust WCM Developing World Equity ETF
3.16%
First Trust WCM International Equity ETF
2.64%
ARK Israel Innovative Technology ETF
1.81%
WealthTrust DBS Long Term Growth ETF
1.42%
WisdomTree International Multifactor Fund
0.77%
iShares Health Innovation Active ETF
0.69%
iShares MSCI Intl Value Factor ETF
0.46%
詳細を見る
iShares MSCI Israel ETF
比率7.76%
VanEck Israel ETF
比率7.5%
VanEck Pharmaceutical ETF
比率3.79%
First Trust WCM Developing World Equity ETF
比率3.16%
First Trust WCM International Equity ETF
比率2.64%
ARK Israel Innovative Technology ETF
比率1.81%
WealthTrust DBS Long Term Growth ETF
比率1.42%
WisdomTree International Multifactor Fund
比率0.77%
iShares Health Innovation Active ETF
比率0.69%
iShares MSCI Intl Value Factor ETF
比率0.46%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
よくある質問
Teva Pharmaceutical Industries Ltdの上位5名の株主は誰ですか？
Teva Pharmaceutical Industries Ltdの上位5名の株主は以下のとおりです。
Phoenix Investment and Finances Ltdは37.76M株を保有しており、これは全体の3.29%に相当します。
Menora Mivtachim Insurance Ltd.は57.40M株を保有しており、これは全体の5.00%に相当します。
Harel Insurance Investments and Financial Services Ltdは33.39M株を保有しており、これは全体の2.91%に相当します。
BlackRock Institutional Trust Company, N.A.は33.89M株を保有しており、これは全体の2.95%に相当します。
Migdal Insurance and Financial Holdings Ltdは28.69M株を保有しており、これは全体の2.50%に相当します。
Phoenix Investment and Finances Ltdは37.76M株を保有しており、これは全体の3.29%に相当します。
Menora Mivtachim Insurance Ltd.は57.40M株を保有しており、これは全体の5.00%に相当します。
Harel Insurance Investments and Financial Services Ltdは33.39M株を保有しており、これは全体の2.91%に相当します。
BlackRock Institutional Trust Company, N.A.は33.89M株を保有しており、これは全体の2.95%に相当します。
Migdal Insurance and Financial Holdings Ltdは28.69M株を保有しており、これは全体の2.50%に相当します。
Teva Pharmaceutical Industries Ltdの株主タイプ上位3種は何ですか？
Teva Pharmaceutical Industries Ltdの株主タイプ上位3種は、
Phoenix Investment and Finances Ltd
Menora Mivtachim Insurance Ltd.
Harel Insurance Investments and Financial Services Ltd
Phoenix Investment and Finances Ltd
Menora Mivtachim Insurance Ltd.
Harel Insurance Investments and Financial Services Ltd
Teva Pharmaceutical Industries Ltd（TEVA）の株式を保有している機関の数はいくつですか？
2025Q3時点で、Teva Pharmaceutical Industries Ltdの株式を保有している機関は1124社あり、保有株式の総市場価値は約742.23Mで、全体の64.70%を占めています。2025Q2と比較して、機関の持ち株は-0.61%増加しています。
Teva Pharmaceutical Industries Ltdの最大の収益源は何ですか？
FY2025Q2において、Generic products部門がTeva Pharmaceutical Industries Ltdにとって最大の収益を生み出しており、その金額は2.41Bで、全収益の57.73%を占めています。
